At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
Positron Emission Tomography +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer: A Pilot Study
In Brief
A clinical study evaluating Positron Emission Tomography, 18F-Fluoro-2-deoxy-D-lucose, and 1 other intervention for Ovarian Cancer and 2 related conditions. Completed, enrolled 5 participants across 1 site.
Detailed Summary
The purpose of this study is to see if Positron Emission Tomography (PET) probes make it easier for your surgeon to find cancer and remove it during your surgery. A PET probe is a wandlike device that can detect radioactivity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Cancer, Fallopian Tube, Primary Peritoneal
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedApr 2013
Primary CompletionDec 2016
TodayJul 2026
First PostedApr 8, 2013
Enrollment StartMar 1, 2013
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 13.2 years ago
Interventions
Positron Emission Tomographyprocedure
18F-Fluoro-2-deoxy-D-lucoseradiation
Cytoreductive surgeryprocedure